• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Kindeva Drug Delivery

Kindeva Drug Delivery has a new COO

April 18, 2024 By Sean Whooley

Denis Johnson Kindeva Drug Delivery COO

Kindeva Drug Delivery announced today that it appointed Denis Johnson as its new chief operating officer (COO). Johnson’s responsibilities include leading global operations for Kindeva’s manufacturing and R&D facilities across the U.S. and UK. The company expects him to facilitate the expansion and opening of the company’s new aseptic injectable fill-finish site in Bridgeton, Missouri. […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Personnel Tagged With: Kindeva Drug Delivery, Personnel Moves

Kindeva Drug Delivery acquires nasal spray company Summit Biosciences

January 18, 2024 By Sean Whooley

kindeva-drug-delivery

Kindeva Drug Delivery announced today that it acquired Summit Biosciences, an intranasal drug-delivery company. Summit, a drug delivery CDMO, brings a track record of innovation in the unit dose nasal spray market. Kindeva believes the acquisition enhances its existing drug delivery capabilities by adding a new platform. This new platform enhances its ability to serve […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Mergers & Acquisitions, Pharmaceuticals Tagged With: Kindeva Drug Delivery, summitbiosciences

Kindeva wins £33M grant from UK to enhance drug-delivering inhalers

August 4, 2023 By Sean Whooley

kindeva-drug-delivery

Kindeva Drug Delivery announced that it received a grant from a UK fund worth a $42.2 million (£33 million) investment. The grant from the UK Government’s Life Sciences Innovation Manufacturing Fund (LSIMF) aims to help Kindeva enhance inhaler manufacturing and sustainability. Funds improve Kindeva’s capability and capacity to manufacture the next generation of green pressurized […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals Tagged With: Kindeva Drug Delivery

Kindeva Drug Delivery names new chief commercial officer

April 5, 2023 By Sean Whooley

David Stevens CCO Kindeva Drug Delivery

Kindeva Drug Delivery announced today that it appointed David Stevens as its global chief commercial officer (CCO). Stevens’ role includes spearheading the commercial, business development and R&D activities for Kindeva. He aims to ensure continued growth, expansion and innovation from the drug delivery device contract development and manufacturing organization (CDMO). “David brings a breadth of […]

Filed Under: Business/Financial News, Contract Services, Drug-Device Combinations, Featured, Personnel Tagged With: Kindeva Drug Delivery, Personnel Moves

Viatris, Kindeva win FDA approval for first generic version of Symbicort inhalation aerosol

March 16, 2022 By Sean Whooley

Viatris Kindeva Drug Delivery

Viatris (Nasdaq:VTRS) and Kindeva Drug Delivery announced today that the FDA approved its generic version of AstraZeneca’s Symbicort. In March 2021, the FDA granted tentative approval to Breyna (Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol) — the first generic version of Symbicort. Today, the agency granted approval for the abbreviated new drug application (ANDA) for […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pharmaceuticals, Regulatory/Compliance, Respiratory Tagged With: AstraZeneca plc, FDA, Kindeva Drug Delivery, Viatris

Kindeva, Cambridge Healthcare Innovations to collaborate on dry-powder inhaler

April 7, 2021 By Sean Whooley

Kindeva Drug Delivery Cambridge Healthcare Innovations Aelous_Device

Kindeva Drug Delivery and Cambridge Healthcare Innovations announced a collaboration to commercialize the latter’s dry-powder inhaler. St. Paul, Minn.-based Kindeva is set to use its product development, regulatory affairs and manufacturing capabilities to help develop and commercialize CHI’s Aeolus dry-powder inhaler (DPI) platform technology, according to a news release. Under the agreement, Kindeva will lead […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals, Respiratory Tagged With: Cambridge Healthcare Innovations, Kindeva Drug Delivery

Sandoz announces in-licensing of Kindeva respiratory inhalation aerosol

March 17, 2021 By Sean Whooley

Sandoz Kindeva Drug Delivery

Sandoz announced that it is in-licensing the commercial distribution rights to a respiratory inhalation medicine from Kindeva Drug Delivery. Princeton, N.J.-based Sandoz in-licensed the rights to the brand and authorized generic of Proventil HFDA (albuterol sulfate) inhalation aerosol, which is immediately available to U.S. patients, according to a news release. Albuterol sulfate is used to […]

Filed Under: Business/Financial News, Contract Services, Drug-Device Combinations, Featured, Pharmaceuticals, Respiratory Tagged With: Kindeva Drug Delivery, sandoz

FDA tentatively approves first generic version of Symbicort inhalation aerosol

March 8, 2021 By Sean Whooley

Viatris Kindeva Drug Delivery

Viatris (NSDQ:VTRS) and Kindeva Drug Delivery announced today that the FDA granted tentative approval of the first generic version of Symbicort. Symbicort, an inhalation aerosol is indicated for certain patients with asthma or chronic obstructive pulmonary disease (COPD). The drug had U.S. branded sales of $3.5 billion for the 12 months ended January 2021, according […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Legal News, Pharmaceuticals, Regulatory/Compliance, Respiratory Tagged With: AstraZeneca plc, FDA, Kindeva Drug Delivery, Viatris

Kindeva Drug Delivery launches as independent company from 3M

May 4, 2020 By Danielle Kirsh

kindeva-drug-delivery

Kindeva Drug Delivery recently announced that it launched as an independent company, shedding its former 3M Drug Delivery Systems name. The formation of the independent company follows its acquisition by Altaris Capital Partners in a transaction that was worth $650 million. Through the acquisition, 3M will hold a 17% minority interest in Kindeva with Altaris. […]

Filed Under: Business/Financial News, Drug-Device Combinations, Mergers & Acquisitions Tagged With: 3M, 3M Drug Delivery Systems, Kindeva Drug Delivery

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS